BOISE, August 20, 2026, 14:20 EDT
- Micron intends to invest $10 billion across ten years in a research laboratory in Boise.
- This represents approximately 55% of its most recent quarterly adjusted free cash flow.
- At 13:49:23 EDT on August 20, Micron’s stock gained 2.10% to reach $956.74.
Shares of Micron Technology, Inc. NASDAQ:MU climbed on Thursday following the company’s announcement of a $10 billion research laboratory in Boise. The initiative is slated to span the next ten years, focusing on advanced memory and computing technologies.
The funding requirement appears relatively small compared to Micron’s present cash flow. In its most recent quarter, the company reported $18.3 billion in adjusted free cash flow. The full ten-year budget for the lab amounts to roughly 55% of that one quarter’s result.
If distributed evenly, the program’s annual cost would be about $1 billion. That represents just 5.5% of free cash flow for the fiscal third quarter. This figure is illustrative and does not serve as company spending guidance.
| Investment and funding test | Amount | Investor read-through |
|---|---|---|
| Boise research facility | $10.0 billion spread across 10 years | Indicates extended R&D funding plan |
| Proposed yearly allocation | $1.0 billion | Equals 5.5% of most recent quarter’s adjusted FCF |
| Adjusted FCF for fiscal Q3 | $18.3 billion | Covers the full lab’s budget 1.83 times |
| Net capital outlay fiscal Q3 | $7.1 billion | Ongoing expansion continues as primary near-term cash allocation |
The difference is significant. Investors are not expected to finance the lab before it turns a profit. Micron is putting capital back into the business following a steep increase in memory prices and higher demand driven by AI.
Revenue for the fiscal third quarter was $41.46 billion, compared to $23.86 billion in the previous quarter and $9.30 billion in the same period last year. GAAP gross margin rose to 84.6%.
| Micron fiscal metric | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| Revenue | $41.46B | $23.86B | $9.30B |
| GAAP gross margin | 84.6% | 74.4% | 37.7% |
| GAAP diluted EPS | $24.67 | $12.07 | $1.68 |
| Operating cash flow | $25.39B | $11.90B | $4.61B |
Chief Executive Sanjay Mehrotra described the quarter as a “record” and stated that the company anticipates an even more robust performance in the fourth quarter. Micron projected revenue at $50 billion, with a margin of plus or minus $1 billion, and gross margin around 86%. Micron outlook and executive remarks
The facility is part of a wider national expansion. In July, Micron increased its projected U.S. investment to over $250 billion by 2035. The company aims to have 40% of its DRAM production based in the United States.
| Current market overview | Value |
|---|---|
| Stock price | $956.74 |
| Change for the day | +2.10% |
| Total market capitalisation | $1.08 trillion |
| P/E ratio | 21.62 |
| Range over 52 weeks | $114.26–$1,255.00 |
Even after Thursday’s increase, the stock was still trading 23.8% beneath its 52-week peak. The size of that gap reflects continued market caution. Memory earnings are susceptible to swift reversals when supply matches demand.
| Analyst | Firm | Latest action | Rating | Target |
|---|---|---|---|---|
| Timothy Arcuri | UBS | Reaffirmed, Aug. 18 | Buy | $1,625 |
| Vivek Arya | Bank of America Securities | Reaffirmed, Aug. 17 | Buy | $1,550 |
| Vijay Rakesh | Mizuho Securities | Reaffirmed, Aug. 10 | Buy | $1,375 |
| Atif Malik | Citi | Held, Aug. 10 | Buy | $1,150 |
| Mark Li | Bernstein | Held, July 27 | Buy | $1,300 |
The consensus appears crowded. According to Google Finance, out of 30 analysts, 29 had buy ratings and one rated the stock as hold, with no sell recommendations. The average price target stood at $1,568.39, representing a 63.9% premium over the current share price.
Micron has begun shipping HBM4 for a major customer’s platform and sent samples to additional clients. HBM4E is set to enter volume production in 2027, marking commercial milestones for the Boise laboratory.
South Korean competitors Samsung Electronics KRX:005930 and SK hynix KRX:000660 are still strong players. The new laboratory will not contribute to wafer production in the short term. Its importance hinges on accelerating process upgrades and successful product launches.
Risks: Returns could be reduced by a decline in memory prices, lower spending on AI infrastructure, delays in construction, or underperformance in HBM yields. In addition, the laboratory’s ten-year schedule creates potential for technology changes or shifts in policy.
Currently, funding is not the main issue. The bigger challenge is if Micron can turn its strong cash flow now into a lasting edge through the next memory market cycle.
Related articles: NASDAQ:MU
The $10B lab is not the cash-flow risk
U.S. market open
Sources: Reuters, Micron fiscal Q3 results, Google Finance. Lab annualization is an illustration, not guidance.
